Fig 1.
Flow chart showing the laboratory procedures of the study.
Table 1.
Demographics and clinical characteristics of culture-positive participants in the Amhara, Gambella, and Benishangul Gumuz regions of Ethiopia, April 2017 to December 2018 (N = 127).
Table 2.
Phenotypic drug resistance pattern of M. tuberculosis Complex isolates for first-line anti-TB drugs in the Amhara, Gambella, and Benishangul Gumuz regions of Ethiopia (N = 127).
Table 3.
Phenotypic drug-resistance pattern of multidrug-resistant M. tuberculosis Complex isolates for second-line anti-TB drugs and PZA in the Amhara, Gambella and Benishangul Gumuz regions of Ethiopia (n = 19).
Table 4.
Mutations associated with isoniazid, rifampicin, fluoroquinolones, and second-line injectable drug-resistant M. tuberculosis Complex isolates.